Predictors of contact tracing completion and outcomes in tuberculosis: a 21-year retrospective cohort study
Birmingham, UK, 1990–2010.
OBJECTIVE:
To identify predictors in contacts for completion of screening and of a positive screening outcome, i.e., a diagnosis of latent tuberculous infection (LTBI) or active tuberculosis (TB).
DESIGN:
A retrospective cohort study of TB notifications for a European city.
RESULTS:
A total of 46 158 contacts were identified from 7365 index cases. Over the study period 17 471 (40.9%) failed to complete screening. Active TB or LTBI was diagnosed in 2220 (7.0%) contacts of cases of pulmonary TB (PTB) and in 222 (2.7%) contacts of cases of extra-pulmonary TB (EPTB). The proportion of contacts offered LTBI treatment increased (P < 0.001) over the study period. Age, ethnicity, sex and use of interferon-gamma release assays (IGRA) were the most important predictors of screening completion, with working age adult males who were Black or from the Indian subcontinent least likely to complete. Age, smear positivity status of the index case and IGRA usage were the most important predictors of a positive screening outcome (active TB or LTBI diagnosed).
CONCLUSION:
Contact tracing of both PTB and EPTB index cases is useful for active case finding. The findings of this study can be used to target screening and improve the effectiveness and efficiency of local contact tracing programmes.
Keywords: infectious disease reporting; interferon-gamma release tests; logistic regression; screening
Document Type: Research Article
Affiliations: 1: Department of Respiratory Medicine, The Royal Liverpool and Broadgreen University Hospitals, Liverpool, UK 2: Warwick Medical School, University of Warwick, Coventry, UK 3: Department of Intensive Care, Sandwell and West Birmingham Hospitals Trust, Birmingham, UK 4: Department of Infection & Tropical Medicine, Heart of England National Health Service Foundation Trust, Birmingham, UK
Publication date: 01 June 2014
The International Journal of Tuberculosis and Lung Disease (IJTLD) is for clinical research and epidemiological studies on lung health, including articles on TB, TB-HIV and respiratory diseases such as COVID-19, asthma, COPD, child lung health and the hazards of tobacco and air pollution. Individuals and institutes can subscribe to the IJTLD online or in print – simply email us at [email protected] for details.
The IJTLD is dedicated to understanding lung disease and to the dissemination of knowledge leading to better lung health. To allow us to share scientific research as rapidly as possible, the IJTLD is fast-tracking the publication of certain articles as preprints prior to their publication. Read fast-track articles.
- Editorial Board
- Information for Authors
- Subscribe to this Title
- International Journal of Tuberculosis and Lung Disease
- Public Health Action
- Ingenta Connect is not responsible for the content or availability of external websites
Receive new issue alert- Access Key
- Free content
- Partial Free content
- New content
- Open access content
- Partial Open access content
- Subscribed content
- Partial Subscribed content
- Free trial content